Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexander Rivkin

Family Medicine Los Angeles, CA Medical Doctor

NPI 1710913223 CMS profile 77133

1033 Gayley Ave, Los Angeles, CA 90024

Open in the dashboard

General payments

$865,872

714 records reported · program years 2019–2025

Research payments

$16,652

Paid to them · 45 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,925,814 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Alexander Rivkin of Los Angeles, CA is reported in the CMS Open Payments database as having received $865,872 across 714 general payments and $16,652 in research payments paid to them. Separately, studies naming them as principal investigator received $1,925,814 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39,569 58
2024 General $145,114 101
2024 Research $13,313 17
2023 General $188,379 117
2023 Research $2,300 20
2022 General $220,248 165
2022 Research $1,039 8
2021 General $102,719 74
2020 General $98,551 55
2019 General $71,292 144

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Rivkin
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Alexander Rivkin were reported at $39,569. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Alexander Rivkin Family Medicine median Middle half National median
2019 $71,292 $150 $41–$543 $163
2020 $98,551 $120 $32–$415 $114
2021 $102,719 $137 $35–$551 $132
2022 $220,248 $137 $37–$512 $149
2023 $188,379 $149 $42–$545 $160
2024 $145,114 $156 $44–$560 $164
2025 $39,569 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $372,929 251 payments
  2. AbbVie, Inc. $266,661 150 payments
  3. Galderma Laboratories, L.P. $152,559 172 payments
  4. Merz North America, Inc. $73,081 132 payments
  5. Revance Therapeutics, Inc. $561 6 payments
  6. Endo Pharmaceuticals Inc. $43 1 payment
  7. Solta Medical, a division of Bausch Health US, LLC $24 1 payment
  8. Musculoskeletal Transplant Foundation Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $488,004 128 payments
  2. Consulting Fee $292,339 59 payments
  3. Travel and Lodging $62,763 112 payments
  4. Food and Beverage $22,545 405 payments
  5. Education $221 10 payments
Products named General payments · program years 2019–2025
  1. BOTOX $240,122 152 payments
  2. BOTOX COSMETIC $87,871 64 payments
  3. Xeomin Dermatology $24,278 82 payments
  4. KYBELLA $1,967 3 payments
  5. ASCLERA $825 16 payments
  6. DAXXIFY $561 6 payments
  7. DYSPORT $283 10 payments
  8. DYSPORT $195 11 payments
  9. Xeomin musculoskeletal $165 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $16,652 45 payments

Records

759 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record